Corcept Therapeutics (CORT) Payables (2016 - 2025)
Historic Payables for Corcept Therapeutics (CORT) over the last 12 years, with Q3 2025 value amounting to $34.4 million.
- Corcept Therapeutics' Payables rose 8535.3% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.4 million, marking a year-over-year increase of 8535.3%. This contributed to the annual value of $15.4 million for FY2024, which is 1161.19% down from last year.
- As of Q3 2025, Corcept Therapeutics' Payables stood at $34.4 million, which was up 8535.3% from $23.5 million recorded in Q2 2025.
- In the past 5 years, Corcept Therapeutics' Payables ranged from a high of $34.4 million in Q3 2025 and a low of $6.6 million during Q3 2021
- Its 5-year average for Payables is $14.3 million, with a median of $12.0 million in 2022.
- In the last 5 years, Corcept Therapeutics' Payables plummeted by 3454.61% in 2021 and then surged by 14428.28% in 2024.
- Quarter analysis of 5 years shows Corcept Therapeutics' Payables stood at $6.9 million in 2021, then surged by 73.36% to $12.0 million in 2022, then skyrocketed by 45.26% to $17.4 million in 2023, then decreased by 11.61% to $15.4 million in 2024, then skyrocketed by 124.02% to $34.4 million in 2025.
- Its Payables was $34.4 million in Q3 2025, compared to $23.5 million in Q2 2025 and $27.9 million in Q1 2025.